BioCentury | Oct 23, 2006
Company News

Hunter-Fleming management update

...Business: Neurology, Autoimmune, Inflammation Hired: Mike Capaldi as CEO and a director, formerly CEO of Synaptica Ltd....
BioCentury | Apr 26, 2004
Company News

Scancell management update

...Scancell Ltd. , Nottingham, U.K. Business: Cancer Hired: Michael Capaldi as CEO, formerly CEO of Synaptica Ltd. WIR...
BioCentury | Oct 21, 2002
Company News

Maybridge plc, Synaptica deal

...chemistry lead optimization for an undisclosed Synaptica program. The companies also will generate compounds for Synaptica...
...for neurological diseases. Maybridge will receive chemistry- and synthesis-related payments. Maybridge plc , Cornwall, U.K. Synaptica Ltd....
BioCentury | Oct 14, 2002
Company News

Maybridge, Synaptica optimization deal

...chemistry lead optimization for an undisclosed Synaptica program. The companies also will generate compounds for Synaptica...
BioCentury | May 20, 2002
Company News

Sanochemia, Synaptica deal

...used to develop third generation therapeutics for Alzheimer's disease and other neurological disorders. In exchange, Synaptica...
...SAC's compounds for use in its own neurodegeneration program. Sanochemia Pharmazeutika AG (NMarkt:SAC), Vienna, Austria Synaptica Ltd....
BioCentury | May 15, 2002
Company News

Sanochemia, Synaptica neurological deal

...used to develop third generation therapeutics for Alzheimer's disease and other neurological disorders. In exchange, Synaptica...
BioCentury | Dec 17, 2001
Company News

Synaptica management update

Synaptica Ltd. , Oxford, U.K. Business: Neurological Hired: Steven Butcher as research director and a director, formerly VP of science at Gemini Genomics plc WIR Staff...
BioCentury | Apr 30, 2001
Company News

Synaptica management update

Synaptica Ltd., Oxford, U.K. Business: Neurological Appointed: Peter Read, former chairman of Hoechst U.K. WIR Staff Neurology...
Items per page:
1 - 8 of 8
BioCentury | Oct 23, 2006
Company News

Hunter-Fleming management update

...Business: Neurology, Autoimmune, Inflammation Hired: Mike Capaldi as CEO and a director, formerly CEO of Synaptica Ltd....
BioCentury | Apr 26, 2004
Company News

Scancell management update

...Scancell Ltd. , Nottingham, U.K. Business: Cancer Hired: Michael Capaldi as CEO, formerly CEO of Synaptica Ltd. WIR...
BioCentury | Oct 21, 2002
Company News

Maybridge plc, Synaptica deal

...chemistry lead optimization for an undisclosed Synaptica program. The companies also will generate compounds for Synaptica...
...for neurological diseases. Maybridge will receive chemistry- and synthesis-related payments. Maybridge plc , Cornwall, U.K. Synaptica Ltd....
BioCentury | Oct 14, 2002
Company News

Maybridge, Synaptica optimization deal

...chemistry lead optimization for an undisclosed Synaptica program. The companies also will generate compounds for Synaptica...
BioCentury | May 20, 2002
Company News

Sanochemia, Synaptica deal

...used to develop third generation therapeutics for Alzheimer's disease and other neurological disorders. In exchange, Synaptica...
...SAC's compounds for use in its own neurodegeneration program. Sanochemia Pharmazeutika AG (NMarkt:SAC), Vienna, Austria Synaptica Ltd....
BioCentury | May 15, 2002
Company News

Sanochemia, Synaptica neurological deal

...used to develop third generation therapeutics for Alzheimer's disease and other neurological disorders. In exchange, Synaptica...
BioCentury | Dec 17, 2001
Company News

Synaptica management update

Synaptica Ltd. , Oxford, U.K. Business: Neurological Hired: Steven Butcher as research director and a director, formerly VP of science at Gemini Genomics plc WIR Staff...
BioCentury | Apr 30, 2001
Company News

Synaptica management update

Synaptica Ltd., Oxford, U.K. Business: Neurological Appointed: Peter Read, former chairman of Hoechst U.K. WIR Staff Neurology...
Items per page:
1 - 8 of 8